| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 10/01/1992 | WO1992016216A1 Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them |
| 10/01/1992 | WO1992016104A1 Leukotriene antagonists |
| 10/01/1992 | CA2083060A1 Process for the extraction of peat and apparatus for carrying out the process |
| 09/30/1992 | WO1992017586A1 Protein having a cytokinin-type activity, recombinant dna coding for this protein, transformed cells and micro-organisms |
| 09/30/1992 | EP0506651A2 Pharmaceutical preparation based on plasma proteins |
| 09/30/1992 | EP0506628A2 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
| 09/30/1992 | EP0506574A1 Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 09/30/1992 | EP0506326A2 Diequitorially bound beta 1-4 polyuronates and use of same for cytokine stimulation |
| 09/30/1992 | EP0505749A2 Monoclonal antibodies directed to activated endothelial cells and their therapeutic and diagnostic use |
| 09/30/1992 | EP0505543A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 09/30/1992 | EP0505434A1 Heterocyclic substituted naphthyridinones and methods and compositions employing them |
| 09/30/1992 | EP0505353A1 Fast printer with a particle trap in the paper channel. |
| 09/29/1992 | US5151534 Antiallergens, antiinflammatory agents or skin disorders |
| 09/29/1992 | US5151498 Immunomodulators and mitogenic agents by extraction, precipitation and filtration |
| 09/29/1992 | US5151423 Antiinflammatory agents or antiallergens |
| 09/29/1992 | US5151360 Antitumor agents or anticarcinogenic agents |
| 09/27/1992 | WO1992017449A1 Stereoselective preparation of substituted piperidines |
| 09/27/1992 | WO1992017426A2 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 09/27/1992 | CA2105158A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 09/23/1992 | WO1992016234A1 Method of modulating mammalian t-cell response |
| 09/23/1992 | EP0505123A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/23/1992 | EP0505122A1 Alpha, alpha-dialkylbenzyl derivatives |
| 09/23/1992 | EP0505058A1 Thienopyridine derivatives and pharmaceutical compositions containing them |
| 09/23/1992 | EP0504799A1 Mixted pyridine-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation, their use as well as medicaments based on these compounds |
| 09/23/1992 | EP0504760A1 Ciclosporin form for pulmonary administration |
| 09/23/1992 | EP0504388A1 Varicella-zoster virus antigen |
| 09/23/1992 | EP0504177A1 A mammalian cytokine, il-11 |
| 09/23/1992 | EP0211899B1 Purification of native colony stimulating factor-1 |
| 09/23/1992 | CA2106567A1 Method of modulating mammalian t-cell response |
| 09/22/1992 | WO1992016235A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | US5149879 Polysulfides compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient |
| 09/22/1992 | US5149718 Biological fluid purification system |
| 09/22/1992 | US5149705 Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
| 09/22/1992 | CA2105378A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2063177A1 Mixed pyridine-2,4- and -2,5-dicarboxamides, a process for preparing them, the use thereof and pharmaceuticals based on these compounds |
| 09/17/1992 | WO1992015671A1 Soluble cd28 proteins and methods of treatment therewith |
| 09/17/1992 | WO1992015599A1 OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015319A1 Hiv protease inhibitors |
| 09/16/1992 | WO1992016494A1 Long chain antiviral compounds |
| 09/16/1992 | WO1992016192A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/16/1992 | EP0504017A1 Benzopyran derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503582A1 Glycyrrhetic acid derivatives |
| 09/16/1992 | EP0503505A1 Purified mite allergen |
| 09/16/1992 | EP0503471A1 Acylaminosubstituted hetrazepines |
| 09/16/1992 | EP0503055A1 Inhibitor of lymphocyte response and immune-related disease |
| 09/16/1992 | EP0503044A1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof. |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | CN1064504A Method for producing kanglemycin c |
| 09/16/1992 | CN1064482A Process for preparing 3-cycloalkyl-propanamides, their tautomer forms and their salts |
| 09/16/1992 | CN1064407A Pharmaceutical composition |
| 09/16/1992 | CA2106068A1 Long chain antiviral compounds |
| 09/15/1992 | WO1992016508A1 Reissert compounds as anti-hiv agents |
| 09/15/1992 | US5147862 Administering a 1,3-glucan |
| 09/15/1992 | US5147652 Alpha ketoaldehydes |
| 09/15/1992 | CA2101335A1 Reissert compounds as anti-hiv agents |
| 09/15/1992 | CA1307522C Pregnane derivatives, processes for their preparation and pharmaceuticalcompositions containing same |
| 09/14/1992 | CA2062652A1 Gylcyrrhetic acid derivatives |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/09/1992 | EP0502550A1 Colominic acid and partial hydrolysis products of colominic acid for the preparation of medicaments for the treatment of hepatitis, nephritis and arthritis |
| 09/09/1992 | EP0502470A2 Compounds for the treatment of inflammation and allergy |
| 09/09/1992 | EP0502188A1 Cloned glutamic acid decarboxylase |
| 09/09/1992 | EP0502171A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
| 09/09/1992 | EP0502106A1 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
| 09/09/1992 | CN1064275A Imidazopyridine paf/h1 antagonists |
| 09/09/1992 | CA2062456A1 Acylamino-substituted hetrazepines |
| 09/09/1992 | CA2062407A1 Benzopirene derivatives, a process for the preparation thereof and the pharmaceutical compositions containing them |
| 09/08/1992 | US5145872 Enzyme inhibitors, analgesics |
| 09/08/1992 | US5145868 Alkanophenones useful for treating allergies |
| 09/08/1992 | US5145850 Imidazopyridazines, their production and use |
| 09/08/1992 | CA2062370A1 Pharmaceutical preparation |
| 09/08/1992 | CA1307279C Octahydro indenofuran derivatives, their preparation and therapeutic compositions containing the same |
| 09/08/1992 | CA1307259C Quinone amides, their production and use |
| 09/03/1992 | WO1992014743A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 09/03/1992 | WO1992014737A1 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 09/03/1992 | WO1992014487A1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans |
| 09/03/1992 | WO1992014485A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 09/02/1992 | EP0501579A1 Naphthalene lactones as inhibitors of leukotriene biosynthesis |
| 09/02/1992 | EP0501578A1 Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| 09/02/1992 | EP0501399A1 Physiologically active kanglemycin C, process for preparing the same and use thereof |
| 09/02/1992 | EP0501321A1 Immunosuppressive drug containing an anti-estradiol antibody |
| 09/02/1992 | EP0501320A1 Immunopotentiating drug containing an anti-testosterone antibody |
| 09/02/1992 | EP0501233A1 Hybridomas and monoclonal antibodies that inhibit anti-CD3-stimulated T cell proliferation |
| 09/02/1992 | EP0501206A2 Phenone compounds, process for their preparation and their pharmaceutical preparations |
| 09/02/1992 | EP0501205A1 Antiphlogistic means |
| 09/02/1992 | EP0500586A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents |
| 09/02/1992 | CN1064079A Steroids |
| 09/02/1992 | CN1064078A Steroid esters |
| 09/02/1992 | CA2061642A1 Physiologically active kanglemycin c, process for preparing the same and use thereof |
| 09/01/1992 | US5144081 Sunscreen agents |
| 09/01/1992 | US5143926 Substituted pyridine-2,4-dicarboxylic acid compounds and methods of use thereof |
| 09/01/1992 | US5143903 Method of treatment with tripeptide pharmaceutical compositions as immunomodulators |
| 09/01/1992 | US5143727 Method for preventing diarrhea |
| 09/01/1992 | CA1306943C Blood products for parenteral administration |
| 08/29/1992 | WO1992015563A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
| 08/29/1992 | CA2104879A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
| 08/29/1992 | CA2061716A1 Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis |
| 08/27/1992 | WO1992014756A1 Therapeutically useful peptides and peptides fragments |